GGrantIndex
← Leaderboards

Sandy S Chang

Dana-Farber Cancer Institute

$11,703,226
Attributed
$11,703,226
Total exposure
15
Grants
13
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $973.8K · FY200525
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$11,703,226 · 15

By mechanism

R01$6,962,959 · 4
R21$1,256,337 · 3
K08$997,343 · 2
P01$856,008 · 1
P30$739,787 · 1
R03$486,000 · 3

Top collaborators

No co-investigators on record.

Most similar at Dana-Farber Cancer Institute

Same institution · by research overlap

Others in their field

Top investigators on “Telomere

Research focus

TelomereMouse ModelMalignant NeoplasmsGenomic InstabilityFunctional DisorderMutationDna DamageResponseComplexTelomere-Binding ProteinsPathway InteractionsLengthChromosome AbnormalityCell LineGenomePreventCellsGenesGeneticPhenotypeProteinsBaseChromosomesGenerations

Grant awards (52)

Mechanisms regulating telomere length, protection and replication$404,792
R35 · FY2025 · GM · contact PI
Role of POT1 in telomere length regulation$335,000
R01 · FY2024 · GM · contact PI
Role of POT1 in telomere length regulation$335,000
R01 · FY2023 · GM · contact PI
Role of POT1 in telomere length regulation$335,000
R01 · FY2022 · GM · contact PI
Telomere dysfunction induced breast cancer pathogenesis$383,156
R01 · FY2020 · CA · contact PI
Exploiting replication stress at telomeres in triple negative breast cancer$167,500
R03 · FY2020 · CA · contact PI
Telomere dysfunction induced breast cancer pathogenesis$371,660
R01 · FY2019 · CA · contact PI
Role of BRIT1 in telomere dysfunctional triple negative breast cancer$83,750
R03 · FY2019 · CA · contact PI
Telomere dysfunction induced breast cancer pathogenesis$383,156
R01 · FY2018 · CA · contact PI
Role of BRIT1 in telomere dysfunctional triple negative breast cancer$83,750
R03 · FY2018 · CA · contact PI
Telomere dysfunction induced breast cancer pathogenesis$383,156
R01 · FY2017 · CA · contact PI
Replicative Senescence as a Tumor Suppressive Mechanism$306,860
R01 · FY2017 · CA · contact PI
Telomere dysfunction and genome instability in familial melanoma$218,588
R21 · FY2017 · CA · contact PI
Telomere dysfunction induced breast cancer pathogenesis$381,822
R01 · FY2016 · CA · contact PI
Replicative Senescence as a Tumor Suppressive Mechanism$306,860
R01 · FY2016 · CA · contact PI
Telomere dysfunction and genome instability in familial melanoma$181,522
R21 · FY2016 · CA · contact PI
Replicative Senescence as a Tumor Suppressive Mechanism$306,860
R01 · FY2015 · CA · contact PI
Understanding alternative non-homologous end joining repair in telomere dysfuncti$181,069
R21 · FY2015 · CA · contact PI
Replicative Senescence as a Tumor Suppressive Mechanism$284,560
R01 · FY2014 · CA · contact PI
Understanding alternative non-homologous end joining repair in telomere dysfuncti$217,283
R21 · FY2014 · CA · contact PI
Telomere replication and maintenance of genome stability$208,125
R21 · FY2014 · AG · contact PI
Replicative senescence as a tumor suppressive mechanism$306,706
R01 · FY2013 · CA · contact PI
Telomere replication and maintenance of genome stability$249,750
R21 · FY2013 · AG · contact PI
Molecular Cytogenetics$152,175
P30 · FY2012 · CA · contact PI
Telomere induced senescence as a supressor of tumorigenesis$25,307
R01 · FY2012 · CA · contact PI
Molecular Cytogenetics$2,882
P30 · FY2012 · CA · contact PI
Telomere induced senescence as a supressor of tumorigenesis$305,017
R01 · FY2011 · CA · contact PI
Molecular Cytogenetics$155,980
P30 · FY2011 · CA · contact PI
Telomere induced senescence as a supressor of tumorigenesis$314,450
R01 · FY2010 · CA · contact PI
Genomic Instability in Familial Cancer Syndromes$191,477
P01 · FY2010 · CA · contact PI
Molecular Cytogenetics$162,279
P30 · FY2010 · CA · contact PI
The role of the telomere capping protein POT1 in mammalian aging$309,386
R01 · FY2009 · AG · contact PI
Telomere induced senescence as a supressor of tumorigenesis$292,600
R01 · FY2009 · CA · contact PI
Genomic Instability in Familial Cancer Syndromes$188,221
P01 · FY2009 · CA · contact PI
Molecular Cytogenetics$163,067
P30 · FY2009 · CA · contact PI
The role of the telomere capping protein POT1 in mammalian aging$309,386
R01 · FY2008 · AG · contact PI
Telomere induced senescence as a supressor of tumorigenesis$292,600
R01 · FY2008 · CA · contact PI
Genomic Instability in Familial Cancer Syndromes$182,340
P01 · FY2008 · CA · contact PI
Molecular Cytogenetics$103,404
P30 · FY2008 · CA · contact PI
Telomere induced senescence as a supressor of tumorigenesis$86,117
R01 · FY2008 · CA · contact PI
The role of the telomere capping protein POT1 in mammalian aging$315,700
R01 · FY2007 · AG · contact PI
Telomere induced senescence as a supressor of tumorigenesis$292,600
R01 · FY2007 · CA · contact PI
Genomic Instability in Familial Cancer Syndromes$178,035
P01 · FY2007 · CA · contact PI
Telomere Induced Genomic Instability in Premature Aging$208,000
K08 · FY2006 · AG · contact PI
Genomic Instability in Familial Cancer Syndromes$115,935
P01 · FY2006 · CA · contact PI
Telomere Induced Genomic Instability in Premature Aging$208,000
K08 · FY2005 · AG
Characterization of a Mouse Model of Werner Syndrome$75,500
R03 · FY2005 · AG
Telomere Induced Genomic Instability in Premature Aging$208,000
K08 · FY2004 · AG
Characterization of a Mouse Model of Werner Syndrome$75,500
R03 · FY2004 · AG
GENOMIC INSTABILITY IN TELOMERASE AND AGING MOUSE MODELS$125,037
K08 · FY2003 · AG
GENOMIC INSTABILITY IN TELOMERASE AND AGING MOUSE MODELS$124,253
K08 · FY2002 · AG
GENOMIC INSTABILITY IN TELOMERASE AND AGING MOUSE MODELS$124,053
K08 · FY2001 · AG